SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (16045)2/28/1998 8:59:00 AM
From: Hippieslayer  Read Replies (1) | Respond to of 32384
 
I only have eyes for youAndrew. You should know that by know.



To: Andrew H who wrote (16045)2/28/1998 7:15:00 PM
From: Cacaito  Read Replies (1) | Respond to of 32384
 
Is Ligand glucocorticoid receptor program with (Glaxo?) in Phase I or Phase II ? This area of research could be the one to generate the $1 billion drug.

Imagine a potent antiinflamatory without all the side effects of the steroids.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News